Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune... see more

TSX:ONC - Post Discussion

Oncolytics Biotech Inc > Timing of Phase III for Panc
View:
Post by Quentin30 on Nov 14, 2022 7:00pm

Timing of Phase III for Panc

Just for clarification. End of Phase II meeting will require a Type C meeting request, this will take 90 days. The end of Phase II meeting will inform what must be included in the Phase III design.

ONCY will need time to author their IND, which FDA could assess within 30 days.

So realistically, the earliest a Phase III or even Phase II/III for Panc could possibly start will be mid Q2 2023.

That may be of value to some here, and could certainly be an inflection point.
Comment by Kswdelux on Nov 14, 2022 7:29pm
Thanks. That does help. Good information. My question to that would be as the original standard Phase II trail was completed back in 2014-2016, some of that process would have already been started and in place. i would assume. I assume the 'Special Protocal' letter and letter of favour, came from that process back in around 2016. The other side trials IND, AWARE-1 and BRACELET-1 ...more  
Comment by Quentin30 on Nov 15, 2022 2:41pm
actually, the end of Phase II meeting leadtime is 75 days, and it's a Type B meeting (not Type C), but effectively they achieve the same thing. But since this trial is not yet complete, I would expect this to be a special meeting with FDA (so a Type C) for whatever they want to discuss. At this meeting, ONCY will present their data to date (or actually before the meeting date), and at the ...more  
Comment by Hcallahan44 on Nov 15, 2022 4:04pm
Thanks Quentin...but what of KSW's point....the BPs are will run the Phase III after an acquisition...i have a biotech savvy friend who says that wont happen...the BPs will hold off and let us do the work....but if KSW is right....this wont be an issue.  The market seems to be saying you are correct....if an acquisition was anywhere near....the stock would be jumping on heavy volume....
Comment by Quentin30 on Nov 15, 2022 6:12pm
HC - from the video link I just posted... Matt states that he 'hopes' to have news of a partnership for shareholders next year... so this would strongly suggest that there is as of now, no BP in the offing. The pps will bounce around $1 - $2 over the next few months... If there is a macro bull run, then it's more likely that ONCY will get left behnd, as traders chase safer profits ...more  
Comment by westcoast1000 on Nov 15, 2022 7:48pm
Quentin, I see it entirely differently. Matt saying he hopes to have news of a partnership next year tells me he IS already in discussions with BP for obvious reasons. The reasons are the results.  But then we all can make our own interpretations of what he said. We will know in the near to distant future, as they say. 
Comment by Buckhenry on Nov 15, 2022 7:51pm
this is my whole point. not one of us are in the know here yet some here think they are omnipotent.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities